OPTN Board approved measures to support new lung allocation policy
Other board actions include approving waiting time modifications for Black kidney candidates disadvantaged by race-inclusive calculations, and updates to NLRB guidance.
UNOS leadership requests USDS engagement concerning leaked report and impact on patients
Leaders in organ donation and transplantation seek meeting and assessment with U.S. Digital Service concerning IT systems that make over 41,000 transplants possible per year.
Infinite Legacy established after OPO merger
The merger brings a combined 79 years of institutional experience together as one organization, serving almost 10 million people across northern Virginia, Washington, D.C. and all of Maryland.
Transplant patient webinar addresses upcoming changes to lung distribution
The OPTN will host a webinar for transplant patients to learn about upcoming changes to lung distribution.
VCA coming to UNet Spring 2023
Audience VCA programs All UNetSM users (for awareness) Implementation date Spring 2023 At-a-glance Allocation of all Vascularized Composite Allograft (VCA) organs will be moving into UNet starting in the Spring of 2023. Additional details There is no action needed...
Three-month monitoring report for heart policy following a device recall now available
Report shows key measures of adult heart allocation based on policy changes implemented in July 2022.
Lung Composite Allocation Score (CAS) calculator coming February 2023
The lung Composite Allocation Score (CAS) calculator will be available on the OPTN website beginning Feb. 2, 2023.
Two-year monitoring report available for the elimination of the use of DSAs in heart allocation
A new data report contains key measures of adult heart allocation based on policy changes implemented in January 2020.
Coming soon: Predictive analytics for adult kidney offers
The goal is to help decision makers make evidence-based decisions to benefit candidates when determining whether to accept or refuse an offer.
Update: CPRA calculation
The new formula for Calculated Panel Reactive Antibody (CPRA) will now go into effect on Jan. 26, 2023.